In - Vitro Studies
Advanced In-Vitro Cytotoxicity, Hemocompatibility And Biocompatibility Testing For Medical Devices As Per ISO 10993
OUR PRE CLINICAL SERVICES
Medical Device In - Vitro Studies
We provide specialized in-vitro biocompatibility testing, cytotoxicity evaluation, and hemocompatibility testing for medical devices in compliance with ISO 10993-5 and international regulatory standards.
In - Vitro Studies Services Scope
In - Vitro Studies for Medical Devices (ISO 10993-5):
In Vitro Cytotoxicity Testing- Medical Device Cytotoxicity Testing – ISO 10993-5
- Hemocompatibility Testing
- In Vitro Skin Irritation Testing
- In Vitro Skin Corrosion Testing
ADVANCE MEDICAL DEVICE TESTING
We Perform Below Mentioned Studies in RRC:
Ribosome Research Centre delivers comprehensive biocompatibility evaluation, toxicological risk assessment, and specialized testing in compliance with OECD GLP, ISO, and global regulatory standards.
Our Process
Our Approach To Accurate &
Compliant Testing
Build your career in a research environment that values scientific curiosity, quality and teamwork. At Ribosome Research Centre, people
contribute to work that supports the understanding of products and the evidence behind development decisions.
Requirement Understanding
We begin by understanding your product, testing requirements, and regulatory objectives to define a clear analytical strategy.
Method Development & Planning
Our team develops and optimizes analytical methods, ensuring alignment with ICH, USP, and global regulatory standards.
Testing & Analysis
Samples are tested using advanced instrumentation such as LC-MS/MS, ICP-MS, and other validated techniques for accurate results.
Reporting & Compliance Support
We deliver detailed, audit-ready reports and provide support for regulatory submissions and compliance requirements.
Stay connected with science
Stay connected with scienceStay Informed. Stay Ahead in Research.
Subscribe to receive the latest updates on pharmaceutical research, clinical and pre-clinical testing, medical device safety, regulatory developments, scientific insights and industry events from Ribosome Research Centre.